FCGR2B and acquired epidermolysis bullosa: The main goal of this study was to assess whether the inhibitory FcγR, FcγRIIB, controls the development of autoimmune skin blistering disease in the active model of EBA, in which we immunized mice with the immunodominant vWFA2 region of COL7.